VRDN Latest Press Releases

-- October 20, 2026 --

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026 Business Wire 4:00 PM

-- August 6, 2026 --

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results Business Wire 7:01 AM

-- June 29, 2026 --

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones Globe Newswire 9:50 AM

-- June 26, 2026 --

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa (veligrotug-vvze) for the Treatment of Thyroid Eye Disease Business Wire 6:00 PM

-- May 27, 2026 --

Viridian Therapeutics to Participate in Upcoming June Investor Conferences Business Wire 7:00 AM

Market Data Delayed 15 Minutes